Evaluating RISQ System Implementation in Acutely Malnourished Children in Chad (CRIMSON)
CRIMSON
Cluster-Randomized Trial of the Implementation of the Responses to Illness Severity Quantification System (RISQ) in Children With Acute Malnutrition Six to Fifty-nine Months of Age in Ngouri, Chad
1 other identifier
interventional
20,000
1 country
1
Brief Summary
The purpose of this study is to evaluate the effect of the Responses to Illness Severity Quantification (RISQ) system implementation on mortality and processes of care in a nutritional program treating children 6 to 59 months of age with acute malnutrition in Ngouri, Chad.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 11, 2023
CompletedFirst Submitted
Initial submission to the registry
October 26, 2023
CompletedFirst Posted
Study publicly available on registry
November 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedNovember 29, 2023
November 1, 2023
12 months
October 26, 2023
November 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All-cause mortality.
Mortality over the period beginning at admission to the program and ending at either program discharge or to a maximum of 60 days after study enrolment. Program discharge will be one of: \[1\] medical/anthropometric criteria or \[2\] defaulting from the program. Defaulting from the program is defined as children who do not attend the weekly clinic visits for 3 consecutive weeks.
12 months
Secondary Outcomes (8)
Timing of inpatient mortality
Duration of hospitalization in days up to 60 days
Timing of outpatient mortality
Duration of program inclusion in days up to 60 days
Therapeutic intensity
First 24 hours from admission to hospital
Efficiency of inpatient care
Duration of hospitalization in days up to 60 days
Workload
Month 1 and month 12
- +3 more secondary outcomes
Other Outcomes (4)
Lived experience of RISQ System implementation
one time at end of 12 month implementation period
comparison of automated versus manual measurements of vital signs (Respiratory rate in breaths/min)
During run-in phase prior to implementation of intervention, on average 2 months
comparison of automated versus manual measurements of vital signs (Temperature in degrees Celsius)
During run-in phase prior to implementation of intervention, on average 2 months
- +1 more other outcomes
Study Arms (2)
Usual Care
NO INTERVENTIONThe 17 health centres randomized to "Usual Care" will provide care as per OptiMA program.
Intervention Arm
EXPERIMENTALThe 17 health centres randomized to the intervention arm will provide care as per OptiMA program with the addition of the RISQ System decision support.
Interventions
The RISQ System involves: \[1\] the RISQ score: calculated routinely using the \[2\] documentation record and linked to \[3\] score-matched recommendations. Introduction into clinical care is supported by \[4\] the RISQ System implementation package. During the 2 month prior to implementation, front-line staff in the intervention arm will be trained on and will practice the use of the RISQ System .
Eligibility Criteria
You may qualify if:
- Children:
- age: 6 to 59 months at enrolment on the day of their admission/re-admission to the OptiMA program
- written consent to participate
- Front line staff providing care to patients enrolled in the Optima program:
- \[1\] Registered Nurses \[2\] Medical Doctors
You may not qualify if:
- Children:
- Children allergic to milk, peanuts and/or ready-to-use therapeutic food (RUTF)
- Children not residing in one of the study areas.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hospital for Sick Childrenlead
- Alliance for International Medical Actioncollaborator
- University of N'Djaména, Chadcollaborator
Study Sites (1)
Ngouri
Ngouri, Chad
Related Publications (3)
Dale NM, Ashir GM, Maryah LB, Shepherd S, Tomlinson G, Briend A, Zlotkin S, Parshuram C. Development and an initial validation of the Responses to Illness Severity Quantification (RISQ) score for severely malnourished children. Acta Paediatr. 2022 Sep;111(9):1752-1763. doi: 10.1111/apa.16410. Epub 2022 Jun 3.
PMID: 35582782BACKGROUNDDale NM, Ashir GM, Maryah LB, Shepherd S, Tomlinson G, Briend A, Zlotkin S, Parshuram CS. Evaluating the Validity of the Responses to Illness Severity Quantification Score to Discriminate Illness Severity and Level of Care Transitions in Hospitalized Children with Severe Acute Malnutrition. J Pediatr. 2023 Nov;262:113609. doi: 10.1016/j.jpeds.2023.113609. Epub 2023 Jul 5.
PMID: 37419241BACKGROUNDDale NM, Hagre YD, Shepherd S, Tomlinson G, Zlotkin S, Ngaradoum M, Bechir M, Madjissem M, Tehoua C, Parshuram C. Cluster-randomized trial of the implementation of the Responses to Illness Severity Quantification (RISQ) system in children with acute malnutrition 6 to 59 months of age in Ngouri, Chad: the CRIMSON trial protocol. Trials. 2025 Jun 3;26(1):188. doi: 10.1186/s13063-025-08871-1.
PMID: 40462129DERIVED
Related Links
- World Health Organization. Guideline: Updates on the Management of Severe Acute Malnutrition in Infants and Children \[Internet\]. 2013.
- World Health Organization. Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses, 2013.
- World Health Organization. Handbook IMCI: Integrated Management of Childhood Illness \[Internet\]. 2005.
- Exploratory meeting to review new evidence for Integrated Management of Childhood Illness (IMCI) danger signs
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher Parshuram, MD, PhD
The Hospital for Sick Children
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The participants and care providers will know which arm of the study they are part of, as the randomization occurs at the facility level. Only the statistician will be blinded to the arms at the time of analysis.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Physician, Paediatric Intensive Care Unit, Department of Critical Care Medicine
Study Record Dates
First Submitted
October 26, 2023
First Posted
November 8, 2023
Study Start
September 11, 2023
Primary Completion
August 31, 2024
Study Completion
October 31, 2024
Last Updated
November 29, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share
On reasonable request - after publication of the study and with permission of parties attached to the study, and after Research Ethics Board review and approval.